Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (108)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,520
Price
$492.97
Total Value
$749.32K
Shares Held After
332,423
% of Holdings
0.5%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
33,000
Price
$97.81
Total Value
$3.23M
Shares Held After
456,209
% of Holdings
6.7%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
533
Price
$95.75
Total Value
$51.03K
Shares Held After
14,219
% of Holdings
3.6%
CYBIN INC. (CYBN)
Halstead Michael — Chief Executive Officer
Shares
100,000
Price
$13.47
Total Value
$1.35M
Shares Held After
168,568
% of Holdings
59.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,667
Price
$95.31
Total Value
$254.20K
Shares Held After
29,995
% of Holdings
8.2%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
601
Price
$94.44
Total Value
$56.76K
Shares Held After
32,662
% of Holdings
1.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,832
Price
$93.32
Total Value
$357.59K
Shares Held After
33,263
% of Holdings
10.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
2,900
Price
$92.37
Total Value
$267.87K
Shares Held After
37,095
% of Holdings
7.3%
Showing 101–108 of 108 transactions (page 3 of 3)